Julie K. Casteel - 10 Nov 2026 Form 4 Insider Report for IBEX Ltd (IBEX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Nov 2026, 18:23:18 UTC
Prior SEC filing
03 Nov 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Lisa Lenstrohm, Attorney-in-Fact
Filing notes and source

Key filing fact

Julie K. Casteel filed Form 4 for IBEX Ltd (IBEX) on 10 Nov 2026.

Key facts

  • This page summarizes Julie K. Casteel's Form 4 filing for IBEX Ltd (IBEX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 10 Nov 2026, 18:23.

Change

  • Previous filing in this sequence was filed on 03 Nov 2026.
  • Current net transaction value: -$592,206.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001974084 Primary reporting owner

Casteel Julie K

Relationship
Chief Sales/Marketing Officer
Address
C/O IBEX LIMITED, 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON
Signature
Lisa Lenstrohm, Attorney-in-Fact
Signature date
10 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IBEX transaction

Common Shares

Sale

Transaction value
-$592,206
Shares
-11,677
Change %
-10%
Price
$50.72
Shares after
100,594
Date
10 Nov 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction was executed in multiple trades at prices ranging from $50.32 to $51.22; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .